Cargando…
G Protein-Coupled Receptor Heteromers as Putative Pharmacotherapeutic Targets in Autism
A major challenge in the development of pharmacotherapies for autism is the failure to identify pathophysiological mechanisms that could be targetable. The majority of developing strategies mainly aim at restoring the brain excitatory/inhibitory imbalance described in autism, by targeting glutamate...
Autores principales: | DelaCuesta-Barrutia, Jon, Peñagarikano, Olga, Erdozain, Amaia M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662108/ https://www.ncbi.nlm.nih.gov/pubmed/33192330 http://dx.doi.org/10.3389/fncel.2020.588662 |
Ejemplares similares
-
Oxytocin as Treatment for Social Cognition, Not There Yet
por: Erdozain, Amaia M., et al.
Publicado: (2020) -
Neuroprotection afforded by targeting G protein-coupled receptors in heteromers and by heteromer-selective drugs
por: Franco, Rafael, et al.
Publicado: (2023) -
Understanding the Added Value of G-Protein-Coupled Receptor Heteromers
por: Franco, Nuria, et al.
Publicado: (2014) -
Ghrelin and Cannabinoid Functional Interactions Mediated by Ghrelin/CB(1) Receptor Heteromers That Are Upregulated in the Striatum From Offspring of Mice Under a High-Fat Diet
por: Lillo, Alejandro, et al.
Publicado: (2021) -
Adenosine A(2A)-dopamine D(2) receptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics
por: Fernández-Dueñas, Víctor, et al.
Publicado: (2018)